Molecular pathogenesis of granulosa cell tumours

Molecular and Cellular Endocrinology

Volumn 191, Issue 1, 2002, Pages 89-96

  Fuller, Peter J ^a   Chu, Simon ^a   Fikret, Sonay ^a   Burger, Henry G ^a  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Estrogen receptor; FSH receptor; Inhibin; Ovary

Indexed keywords

ACTIVIN; ESTROGEN RECEPTOR; FOLLITROPIN; FOLLITROPIN RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; INHIBIN; ACTIVIN RECEPTOR; RECEPTOR;

ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; GRANULOSA CELL TUMOR; HUMAN; MOUSE; NONHUMAN; OVARY TUMOR; PATHOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; FEMALE; GENE EXPRESSION REGULATION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ACTIVIN RECEPTORS; ACTIVINS; ANIMAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GRANULOSA CELL TUMOR; INHIBINS; OVARIAN NEOPLASMS; RECEPTORS, ESTROGEN; RECEPTORS, FSH; RECEPTORS, PEPTIDE; SIGNAL TRANSDUCTION; SUPPORT, NON-U.S. GOV'T; ANIMALS;

EID: 0037204682     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(02)00059-X     Document Type: Article

References (73)

1. Is potential to produce inhibins related to prognosis in ovarian granulosa cell tumors
2. Control of differentiation, transformation and apoptosis in granulosa cells by oncogenes, oncoviruses, and tumor suppressor genes
3. Ovarian surface epithelium: biology, endocrinology, and pathology
4. Inhibin binding protein in rats: alternative transcripts and regulation in the pituitary across the estrous cycle
5. Serum inhibin and disease status in women with ovarian granulosa cell tumors
6. Use of tissue-specific promoters in the regulation of aromatase cytochrome P450 gene expression in human testicular and ovarian sex cord tumors, as well as in normal fetal and adult gonads
7. Characterization of inhibin immunoreactivity in post-menopausal women with ovarian tumors
8. Modulation of activin signal transduction by inhibin B and inhibin-binding protein (InhBP)
9. Structure and expression of a membrane component of the inhibin receptor system
10. Identification of a splice variant of the rat estrogen receptor β gene
11. Estrogen receptor isoform gene expression in ovarian stromal and epithelial tumors
12. Follistatin is a modulator of gonadal tumor progression and the activin-induced wasting syndrome in inhibin-deficient mice
13. Activin signalling through activin receptor type II causes the cachexia-like symptoms in inhibin-deficient mice
14. Expression of estrogen receptor-beta in human breast tumors
15. The cell of origin of ovarian epithelial tumors and the ovarian surface epithelium dogma: does the emperor have no clothes
16. Human estrogen receptor β gene structure, chromosomal localisation and expression pattern
17. Activating mutation of the stimulatory G protein (gsp) as a putative cause of ovarian and testicular human stromal Leydig cell tumors
18. No evidence of a role for mutations or polymorphisms of the follicle-stimulating hormone receptor in ovarian granulosa cell tumors
19. Inhibin subunit gene expression in ovarian cancer
20. The coregulator exchange in transcriptional functions of nuclear receptors
21. Adenylate cyclase in human ovarian cancers: sensitivity to gonadotropins and nonhormonal activators
22. An activating mutation of the follicle-stimulating hormone receptor autonomously sustains spermatogenesis in a hypophysectomized man
23. Measurement of dimeric inhibin B throughout the human menstrual cycle
24. The hallmarks of cancer
25. Functional analysis of a novel estrogen receptor-β isoform
26. Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors
27. TGF-β signalling from cell membrane to nucleus through SMAD proteins
28. Comment on analysis of mutations in genes of the follicle-stimulating hormone receptor in granulosa cell tumors
29. A prospective study of inhibin in granulosa cell tumors of the ovary
30. Luteinizing hormone induction of ovarian tumors: oligogenic differences between mouse strains dictates tumor disposition
31. A mutation in the follicle-stimulating hormone receptor occurs frequently in human ovarian sex cord tumors
32. Absence of mutations in the FSH receptor in ovarian granulosa cell tumors
33. Cloning of a novel estrogen receptor expressed in rat prostate and ovary
34. Gonadotropins are essential modifier factors for gonadal tumor development in inhibin-deficient mice
35. Transgenic models to study gonadotropin function: the role of follicle-stimulating hormone in gonadal growth and tumorigenesis
36. GTPase inhibiting mutations activate the α-chain of Gs and stimulate adenylyl cyclase in human pituitary tumours
37. Inhibin as a marker for granulosa cell tumors
38. Betaglycan binds inhibin and can mediate functional antagonism of activin signalling
39. Analysis of mutations in genes of the follicle-stimulating hormone receptor signaling pathway in ovarian granulosa cell tumors
40. Leydig-cell tumors caused by an activating mutation of the gene encoding the luteinizing hormone receptor
41. Estrogen receptor-β mRNA variants in human and murine tissues
42. Two G protein oncogenes in human endocrine tumors
43. Inhibin A, inhibin B and activin A in the follicular fluid of regularly cycling women
44. A novel isoform of rat estrogen receptor beta with 18 amino acid insertion in the ligand binding domain as a putative dominant negative regulator of estrogen action
45. How cells read TGF-β signals
46. TGFβ signaling in growth control, cancer, and heritable disorders
47. Development of cancer cachexia-like syndrome and adrenal tumors in inhibin deficient mice
48. α Inhibin is a tumor-suppressor gene with gonadal specificity in mice
49. Transgenic models to study the roles of inhibins and activins in reproduction, oncogenesis, and development
50. Editorial: in search of binding-identification of inhibin receptors
51. Cloning and characterization of human estrogen receptor β isoforms
52. ERβ: identification and characterization of a novel human estrogen receptor
53. Molecular cloning and characterization of human estrogen receptor betacx: a potential inhibitor of estrogen action in human
54. Are estrogens of import to primate/human ovarian folliculogenesis
55. 2, a functional variant of estrogen receptor β expressed in normal rat tissues
56. Inhibin B is the major form of inhibin/activin family secreted by granulosa cell tumors
57. Hormonal control of gene expression in the ovary
58. New signaling pathways for hormones and cyclic adenosine 3′, 5′-monophosphate action in endocrine cells
59. Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence
60. Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors
61. Expression of inhibin/activin subunits and follistatin messenger ribonucleic acids and proteins in ovarian follicles and the corpus luteum during the human menstrual cycle
62. Inhibin forms in serum from postmenopausal women with ovarian cancers
63. Ovarian tumors in a cohort of infertile women
64. Absence of the previously reported G protein oncogene (gip 2) in ovarian granulosa cell tumors
65. Characterization of gonadal sex cord-stromal tumor cell lines from inhibin-α and p53-deficient mice: the role of activin as an autocrine growth factor
66. Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis
67. Investigation of binding sites for follicle-stimulating hormone and chorionic gonadotropin in human ovarian cancers
68. Breast and ovarian cancer incidence after infertility and in vitro fertilisation
69. Expression of estrogen receptor beta messenger RNA variant in breast cancer
70. Ovarian stimulation and granulosa-cell tumour